Answers are grounded in this paper and cite their sources.
Background Managing health information is one of the greatest challenges in modern health care. In Belgium, decentralization and fragmentation further complicate interoperability. Primary data, collected through electronic health records, and secondary data, used for research and policy, require distinct approaches. Fast Healthcare Interoperability Resources (FHIR) enables real-time clinical data exchange, while the Observational Medical Outcomes Partnership (OMOP) model standardizes heterogeneous datasets for large-scale analysis. Objective The goal of this study was to assess the strengths, weaknesses, and feasibility of using FHIR and OMOP together in the context of Belgian health care to identify barriers and opportunities for their combined use. Methods To answer the research questions, a mixed methods approach was used (using both qualitative and quantitative methods). This included an analysis of FHIR and OMOP technical documentation and technical literature as well as semistructured interviews with 8 research experts drawn from 3 professional backgrounds, including health data governance, clinical practice, and biomedical research. Results Findings show that primary data use is facilitated by FHIR by improved electronic health record interoperability, public health surveillance, and clinical decision support. However, adoption is hindered by constant updates, economic constraints, and fragmented regulation. OMOP demonstrates great potential for secondary data, facilitating harmonized epidemiological studies, pharmacovigilance, and global collaboration. Integration with legacy systems, high costs, and low granularity are major obstacles. Experts identified clinicians as essential for ensuring data quality and highlighted their importance in preventing administrative burden and encouraging uptake by training and designing user-friendly tools. Conclusions FHIR and OMOP complement one another in addressing disparate but connected sides of the reuse of health information. Both together can enhance interoperability, streamline clinical workflows, and expand the ability to perform research. Achieving this requires targeted investment, regulatory alignment, and clinician engagement, placing Belgium at the forefront of digital health innovation in Europe.
No takes yet. Share an insight, caveat, or question.
Lechhab et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: